Vertebroplasty And Kyphoplasty Needles Market Size, Share & Trends Analysis Report By Procedure (Kyphoplasty Procedures), By End Use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 3 Business Days
Vertebroplasty And Kyphoplasty Needles Market Growth & Trends
The global vertebroplasty and kyphoplasty needles market size is expected treach USD 1,210.2 million in 2030 and is anticipated tgrow at a CAGR of 4.9% over the forecast period. Increasing geriatric population prone tvertebral disorders and demand for minimally invasive procedures due tthe fewer risks associated with them is boosting market growth.
Increase in incidence rates of injuries associated with adventure, sports, and accidents are alsanticipated tboost market growth. As per the 2018, Database of the National Spinal Cord Injury, round 6.0% of new cases of spinal cord injury were reported in U.S. of which 38.0% were due tvehicle accidents and 8.0% due tsports injury.
The prevalence of vertebral compression fractures increases with age and is one of the most common sequelae of osteoporosis. There are around 7,50,000 new vertebral compression fractures every year in U.S. with resultant chronic and acute pain in over one-third of the patients with vertebral fractures.
Patients with VCFs generally experience severe back pain that may limit mobility. The vertebroplasty and balloon kyphoplasty procedures have been proven successful in restoring vertebral height and strength and are capable of reducing pain in patients. There is a high demand for the procedures as they are minimally invasive and possess low risks as compared tthe larger open spinal fusion surgery.
The American Society for Bone and Mineral Research has established a Task Force taddress the safety and efficacy of vertebral augmentation and other methods ttreat the vertebral compression fractures as there is a lack of consent regarding the safety and efficacy of both medical procedures.
Vertebroplasty And Kyphoplasty Needles Market Report Highlights
Vertebroplasty And Kyphoplasty Needles Market Growth & Trends
The global vertebroplasty and kyphoplasty needles market size is expected treach USD 1,210.2 million in 2030 and is anticipated tgrow at a CAGR of 4.9% over the forecast period. Increasing geriatric population prone tvertebral disorders and demand for minimally invasive procedures due tthe fewer risks associated with them is boosting market growth.
Increase in incidence rates of injuries associated with adventure, sports, and accidents are alsanticipated tboost market growth. As per the 2018, Database of the National Spinal Cord Injury, round 6.0% of new cases of spinal cord injury were reported in U.S. of which 38.0% were due tvehicle accidents and 8.0% due tsports injury.
The prevalence of vertebral compression fractures increases with age and is one of the most common sequelae of osteoporosis. There are around 7,50,000 new vertebral compression fractures every year in U.S. with resultant chronic and acute pain in over one-third of the patients with vertebral fractures.
Patients with VCFs generally experience severe back pain that may limit mobility. The vertebroplasty and balloon kyphoplasty procedures have been proven successful in restoring vertebral height and strength and are capable of reducing pain in patients. There is a high demand for the procedures as they are minimally invasive and possess low risks as compared tthe larger open spinal fusion surgery.
The American Society for Bone and Mineral Research has established a Task Force taddress the safety and efficacy of vertebral augmentation and other methods ttreat the vertebral compression fractures as there is a lack of consent regarding the safety and efficacy of both medical procedures.
Vertebroplasty And Kyphoplasty Needles Market Report Highlights
- The kyphoplasty procedures segment accounted for the largest share of 60.4% in 2024. Kyphoplasty is the advanced version of vertebroplasty and can reduce deformities, restore heights, and stabilize fractures and are three times more commonly performed than the other procedure
- Based on end-use, the ambulatory surgical center segment is anticipated tregister the fastest growth due tthe increasing demand for modern healthcare facilities
- The hospitals segment dominated the market with a share of 59.7% in 2024. The increasing prevalence of spinal disorders, particularly osteoporosis, is driving demand for vertebroplasty and kyphoplasty in hospitals.
- North America vertebroplasty and kyphoplasty needles market held the largest share of 39.4% in 2024. This is due tthe rising demand for minimally invasive procedures as well as the presence of the large number of players that cater tthe devices for the treatment of VCF.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Procedure
1.2.2. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. VERTEBROPLASTY AND KYPHOPLASTY NEEDLES MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
CHAPTER 4. VERTEBROPLASTY AND KYPHOPLASTY NEEDLES MARKET: PROCEDURE BUSINESS ANALYSIS
4.1. Procedure Market Share, 2024 & 2030
4.2. Procedure Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Procedure, 2018 to 2030 (USD Million)
4.4. Kyphoplasty Procedures
4.4.1. Kyphoplasty procedures market, 2018 - 2030 (USD Million)
4.5. Vertebroplasty Procedures
4.5.1. Vertebroplasty procedures market, 2018 - 2030 (USD Million)
4.5.2. Directional Vertebroplasty Needles
4.5.2.1. Directional vertebroplasty needles market, 2018 - 2030 (USD Million)
4.5.3. Straight Vertebroplasty Needles
4.5.3.1. Straight vertebroplasty needles market, 2018 - 2030 (USD Million)
CHAPTER 5. VERTEBROPLASTY AND KYPHOPLASTY NEEDLES MARKET: END USE BUSINESS ANALYSIS
5.1. End Use Market Share, 2024 & 2030
5.2. End Use Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Hospitals
5.4.1. Hospitals market, 2018 - 2030 (USD Million)
5.5. Ambulatory Surgical Centers
5.5.1. Ambulatory surgical centers market, 2018 - 2030 (USD Million)
CHAPTER 6. VERTEBROPLASTY AND KYPHOPLASTY NEEDLES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY PROCEDURE AND END USE
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. North America vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Key country dynamic
6.4.2.2. Regulatory framework
6.4.2.3. Competitive insights
6.4.2.4. U.S. vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.3. Canada
6.4.3.1. Key country dynamic
6.4.3.2. Regulatory framework
6.4.3.3. Competitive insights
6.4.3.4. Canada vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.4. Mexico
6.4.4.1. Key country dynamic
6.4.4.2. Regulatory framework
6.4.4.3. Competitive insights
6.4.4.4. Mexico vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.5. Europe
6.5.1. Europe vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.2. UK
6.5.2.1. Key country dynamic
6.5.2.2. Regulatory framework
6.5.2.3. Competitive insights
6.5.2.4. UK vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.3. Germany
6.5.3.1. Key country dynamic
6.5.3.2. Regulatory framework
6.5.3.3. Competitive insights
6.5.3.4. Germany vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.4. France
6.5.4.1. Key country dynamic
6.5.4.2. Regulatory framework
6.5.4.3. Competitive insights
6.5.4.4. France vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.5. Italy
6.5.5.1. Key country dynamic
6.5.5.2. Regulatory framework
6.5.5.3. Competitive insights
6.5.5.4. Italy vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.6. Spain
6.5.6.1. Key country dynamic
6.5.6.2. Regulatory framework
6.5.6.3. Competitive insights
6.5.6.4. Spain vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.7. Denmark
6.5.7.1. Key country dynamic
6.5.7.2. Regulatory framework
6.5.7.3. Competitive insights
6.5.7.4. Denmark vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.8. Sweden
6.5.8.1. Key country dynamic
6.5.8.2. Regulatory framework
6.5.8.3. Competitive insights
6.5.8.4. Sweden vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.9. Norway
6.5.9.1. Key country dynamic
6.5.9.2. Regulatory framework
6.5.9.3. Competitive insights
6.5.9.4. Norway vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.2. Japan
6.6.2.1. Key country dynamic
6.6.2.2. Regulatory framework
6.6.2.3. Competitive insights
6.6.2.4. Japan vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.3. China
6.6.3.1. Key country dynamic
6.6.3.2. Regulatory framework
6.6.3.3. Competitive insights
6.6.3.4. China vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.4. India
6.6.4.1. Key country dynamic
6.6.4.2. Regulatory framework
6.6.4.3. Competitive insights
6.6.4.4. India vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.5. Australia
6.6.5.1. Key country dynamic
6.6.5.2. Regulatory framework
6.6.5.3. Competitive insights
6.6.5.4. Australia vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.6. South Korea
6.6.6.1. Key country dynamic
6.6.6.2. Regulatory framework
6.6.6.3. Competitive insights
6.6.6.4. South Korea vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.7. Thailand
6.6.7.1. Key country dynamic
6.6.7.2. Regulatory framework
6.6.7.3. Competitive insights
6.6.7.4. Thailand vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.7. Latin America
6.7.1. Latin America vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key country dynamic
6.7.2.2. Regulatory framework
6.7.2.3. Competitive insights
6.7.2.4. Brazil vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key country dynamic
6.7.3.2. Regulatory framework
6.7.3.3. Competitive insights
6.7.3.4. Argentina vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.8. MEA
6.8.1. MEA vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key country dynamic
6.8.2.2. Regulatory framework
6.8.2.3. Competitive insights
6.8.2.4. South Africa vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key country dynamic
6.8.3.2. Regulatory framework
6.8.3.3. Competitive insights
6.8.3.4. Saudi Arabia vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key country dynamic
6.8.4.2. Regulatory framework
6.8.4.3. Competitive insights
6.8.4.4. UAE vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key country dynamic
6.8.5.2. Regulatory framework
6.8.5.3. Competitive insights
6.8.5.4. Kuwait vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. Stryker
7.5.1.1. Overview
7.5.1.2. Financial performance
7.5.1.3. Product benchmarking
7.5.1.4. Strategic initiatives
7.5.2. Medtronic
7.5.2.1. Overview
7.5.2.2. Financial performance
7.5.2.3. Product benchmarking
7.5.2.4. Strategic initiatives
7.5.3. IZI Medical Products
7.5.3.1. Overview
7.5.3.2. Financial performance
7.5.3.3. Product benchmarking
7.5.3.4. Strategic initiatives
7.5.4. Globus Medical
7.5.4.1. Overview
7.5.4.2. Financial performance
7.5.4.3. Product benchmarking
7.5.4.4. Strategic initiatives
7.5.5. BPB medica - Biopsybell
7.5.5.1. Overview
7.5.5.2. Financial performance
7.5.5.3. Product benchmarking
7.5.5.4. Strategic initiatives
7.5.6. Teknimed
7.5.6.1. Overview
7.5.6.2. Financial performance
7.5.6.3. Product benchmarking
7.5.6.4. Strategic initiatives
7.5.7. Merit Medical Systems
7.5.7.1. Overview
7.5.7.2. Financial performance
7.5.7.3. Product benchmarking
7.5.7.4. Strategic initiatives
7.5.8. ZAVATION
7.5.8.1. Overview
7.5.8.2. Financial performance
7.5.8.3. Product benchmarking
7.5.8.4. Strategic initiatives
7.5.9. RONTIS
7.5.9.1. Overview
7.5.9.2. Financial performance
7.5.9.3. Product benchmarking
7.5.9.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Procedure
1.2.2. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. VERTEBROPLASTY AND KYPHOPLASTY NEEDLES MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
CHAPTER 4. VERTEBROPLASTY AND KYPHOPLASTY NEEDLES MARKET: PROCEDURE BUSINESS ANALYSIS
4.1. Procedure Market Share, 2024 & 2030
4.2. Procedure Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Procedure, 2018 to 2030 (USD Million)
4.4. Kyphoplasty Procedures
4.4.1. Kyphoplasty procedures market, 2018 - 2030 (USD Million)
4.5. Vertebroplasty Procedures
4.5.1. Vertebroplasty procedures market, 2018 - 2030 (USD Million)
4.5.2. Directional Vertebroplasty Needles
4.5.2.1. Directional vertebroplasty needles market, 2018 - 2030 (USD Million)
4.5.3. Straight Vertebroplasty Needles
4.5.3.1. Straight vertebroplasty needles market, 2018 - 2030 (USD Million)
CHAPTER 5. VERTEBROPLASTY AND KYPHOPLASTY NEEDLES MARKET: END USE BUSINESS ANALYSIS
5.1. End Use Market Share, 2024 & 2030
5.2. End Use Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Hospitals
5.4.1. Hospitals market, 2018 - 2030 (USD Million)
5.5. Ambulatory Surgical Centers
5.5.1. Ambulatory surgical centers market, 2018 - 2030 (USD Million)
CHAPTER 6. VERTEBROPLASTY AND KYPHOPLASTY NEEDLES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY PROCEDURE AND END USE
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. North America vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Key country dynamic
6.4.2.2. Regulatory framework
6.4.2.3. Competitive insights
6.4.2.4. U.S. vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.3. Canada
6.4.3.1. Key country dynamic
6.4.3.2. Regulatory framework
6.4.3.3. Competitive insights
6.4.3.4. Canada vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.4. Mexico
6.4.4.1. Key country dynamic
6.4.4.2. Regulatory framework
6.4.4.3. Competitive insights
6.4.4.4. Mexico vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.5. Europe
6.5.1. Europe vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.2. UK
6.5.2.1. Key country dynamic
6.5.2.2. Regulatory framework
6.5.2.3. Competitive insights
6.5.2.4. UK vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.3. Germany
6.5.3.1. Key country dynamic
6.5.3.2. Regulatory framework
6.5.3.3. Competitive insights
6.5.3.4. Germany vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.4. France
6.5.4.1. Key country dynamic
6.5.4.2. Regulatory framework
6.5.4.3. Competitive insights
6.5.4.4. France vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.5. Italy
6.5.5.1. Key country dynamic
6.5.5.2. Regulatory framework
6.5.5.3. Competitive insights
6.5.5.4. Italy vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.6. Spain
6.5.6.1. Key country dynamic
6.5.6.2. Regulatory framework
6.5.6.3. Competitive insights
6.5.6.4. Spain vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.7. Denmark
6.5.7.1. Key country dynamic
6.5.7.2. Regulatory framework
6.5.7.3. Competitive insights
6.5.7.4. Denmark vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.8. Sweden
6.5.8.1. Key country dynamic
6.5.8.2. Regulatory framework
6.5.8.3. Competitive insights
6.5.8.4. Sweden vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.9. Norway
6.5.9.1. Key country dynamic
6.5.9.2. Regulatory framework
6.5.9.3. Competitive insights
6.5.9.4. Norway vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.2. Japan
6.6.2.1. Key country dynamic
6.6.2.2. Regulatory framework
6.6.2.3. Competitive insights
6.6.2.4. Japan vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.3. China
6.6.3.1. Key country dynamic
6.6.3.2. Regulatory framework
6.6.3.3. Competitive insights
6.6.3.4. China vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.4. India
6.6.4.1. Key country dynamic
6.6.4.2. Regulatory framework
6.6.4.3. Competitive insights
6.6.4.4. India vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.5. Australia
6.6.5.1. Key country dynamic
6.6.5.2. Regulatory framework
6.6.5.3. Competitive insights
6.6.5.4. Australia vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.6. South Korea
6.6.6.1. Key country dynamic
6.6.6.2. Regulatory framework
6.6.6.3. Competitive insights
6.6.6.4. South Korea vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.7. Thailand
6.6.7.1. Key country dynamic
6.6.7.2. Regulatory framework
6.6.7.3. Competitive insights
6.6.7.4. Thailand vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.7. Latin America
6.7.1. Latin America vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key country dynamic
6.7.2.2. Regulatory framework
6.7.2.3. Competitive insights
6.7.2.4. Brazil vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key country dynamic
6.7.3.2. Regulatory framework
6.7.3.3. Competitive insights
6.7.3.4. Argentina vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.8. MEA
6.8.1. MEA vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key country dynamic
6.8.2.2. Regulatory framework
6.8.2.3. Competitive insights
6.8.2.4. South Africa vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key country dynamic
6.8.3.2. Regulatory framework
6.8.3.3. Competitive insights
6.8.3.4. Saudi Arabia vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key country dynamic
6.8.4.2. Regulatory framework
6.8.4.3. Competitive insights
6.8.4.4. UAE vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key country dynamic
6.8.5.2. Regulatory framework
6.8.5.3. Competitive insights
6.8.5.4. Kuwait vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. Stryker
7.5.1.1. Overview
7.5.1.2. Financial performance
7.5.1.3. Product benchmarking
7.5.1.4. Strategic initiatives
7.5.2. Medtronic
7.5.2.1. Overview
7.5.2.2. Financial performance
7.5.2.3. Product benchmarking
7.5.2.4. Strategic initiatives
7.5.3. IZI Medical Products
7.5.3.1. Overview
7.5.3.2. Financial performance
7.5.3.3. Product benchmarking
7.5.3.4. Strategic initiatives
7.5.4. Globus Medical
7.5.4.1. Overview
7.5.4.2. Financial performance
7.5.4.3. Product benchmarking
7.5.4.4. Strategic initiatives
7.5.5. BPB medica - Biopsybell
7.5.5.1. Overview
7.5.5.2. Financial performance
7.5.5.3. Product benchmarking
7.5.5.4. Strategic initiatives
7.5.6. Teknimed
7.5.6.1. Overview
7.5.6.2. Financial performance
7.5.6.3. Product benchmarking
7.5.6.4. Strategic initiatives
7.5.7. Merit Medical Systems
7.5.7.1. Overview
7.5.7.2. Financial performance
7.5.7.3. Product benchmarking
7.5.7.4. Strategic initiatives
7.5.8. ZAVATION
7.5.8.1. Overview
7.5.8.2. Financial performance
7.5.8.3. Product benchmarking
7.5.8.4. Strategic initiatives
7.5.9. RONTIS
7.5.9.1. Overview
7.5.9.2. Financial performance
7.5.9.3. Product benchmarking
7.5.9.4. Strategic initiatives
